NCT03836586

Brief Summary

This study proposes to experimentally manipulate pain catastrophizing in order to investigate the neural mechanisms by which pain catastrophizing influences the experience of pain among non-Hispanic Blacks (NHBs) and non- Hispanic Whites (NHWs) with knee osteoarthritis (OA). Therefore, participants will be randomized to either a single session cognitive-behavioral intervention to reduce pain catastrophizing or a pain education control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 11, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

December 23, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2021

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

December 22, 2022

Completed
Last Updated

April 19, 2024

Status Verified

November 1, 2022

Enrollment Period

1.5 years

First QC Date

February 8, 2019

Results QC Date

August 22, 2022

Last Update Submit

April 17, 2024

Conditions

Keywords

catastrophizingcognitive-behavior therapy

Outcome Measures

Primary Outcomes (1)

  • Pain Catastrophizing Scale (PCS) at Day 2

    13-item scale that assesses catastrophic thinking associated with pain. The study team will administer the PCS using traditional instructions (a measure of trait catastrophizing) and instructions to assess situation-specific catastrophizing ("Thinking back to your experience during the laboratory pain testing"). Thoughts and feelings concerning pain are ranked on a 0-4 scale, with 0 being the patient has this thought/feeling 'not at all' to 4, the patient has this thought feeling 'all the time.' The PCS total score is computed by summing responses to all 13 items. PCS total scores range from 0 - 52. Higher scores indicate the presence of catastrophizing and therefore worse outcome.

    Day 2

Study Arms (2)

Pain Catastrophizing Reduction Group

EXPERIMENTAL

This group will be assigned to a 30-minute, single-session cognitive-behavioral intervention designed to reduce pain catastrophizing.

Behavioral: Cognitive-Behavioral Intervention

Pain Education Group

ACTIVE COMPARATOR

This group will receive general information about the neurobiology of pain and knee OA.

Behavioral: Pain Education

Interventions

This intervention comprises three components: 1) general education about pain (e.g., pain pathways) and a rationale for the intervention (e.g., gate control theory); 2) impact of positive and negative pain-related thoughts on neural process of pain; and 3) a guided imaginal pain exposure exercise.

Pain Catastrophizing Reduction Group
Pain EducationBEHAVIORAL

General information about the neurobiology of pain and knee osteoarthritis will be given to participants assigned to this intervention.

Pain Education Group

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • symptomatic knee OA

You may not qualify if:

  • Younger than 45 years of age or older than 85 years of age
  • Prosthetic knee replacement or other clinically significant surgery to the arthritic knee
  • uncontrolled hypertension (\>150/95)
  • Heart disease including heart failure
  • Peripheral neuropathy in which pain testing was contraindicated
  • Systemic rheumatic disorders including rheumatoid arthritis, systemic lupus erythematosus, gout, and fibromyalgia
  • Neurological diseases such as Parkinson's, multiple sclerosis, stroke with loss of sensory or motor function, or uncontrolled seizures
  • Significantly greater pain in body sites other than in the knee
  • Daily opioid use
  • Hospitalization within the preceding year for psychiatric illness
  • Currently pregnant or nursing/breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health at the University of Florida

Gainesville, Florida, 32610, United States

Location

Results Point of Contact

Title
Dr. Ellen Terry
Organization
University of Florida

Study Officials

  • Ellen Terry, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomized to either a single session cognitive-behavioral intervention to reduce pain catastrophizing or a pain education control group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 11, 2019

Study Start

December 23, 2019

Primary Completion

June 7, 2021

Study Completion

June 7, 2021

Last Updated

April 19, 2024

Results First Posted

December 22, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations